NSC 370284 is a direct STAT3/5 inhibitor that selectively targets and reduces the viability of acute myeloid leukemia (AML) cells exhibiting high TET1 expression. Its efficacy has been demonstrated in both cellular assays and animal models, supporting its use as a research tool for studying oncogenic signaling in AML.